Chuanrong Chen

Wuhu, 241000, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

PDK4 acts via hippo signaling to inhibit ferroptosis and reduce gemcitabine sensitivity in pancreatic cancer.

PDK4 acts via hippo signaling to inhibit ferroptosis and reduce gemcitabine sensitivity in pancreatic cancer.

Journal: Journal of molecular histology

Published: November 21, 2025

UBE2C promotes cell cycle progression and suppresses DNA damage-induced apoptosis in triple-negative breast cancer.

UBE2C promotes cell cycle progression and suppresses DNA damage-induced apoptosis in triple-negative breast cancer.

Journal: DNA repair

Published: June 30, 2025

Decoy Extracellular Vesicles Overcome Triple-Negative Breast Cancer Heterogeneity via Membrane-Cytoplasm-Mitochondria Cascade Targeting.

Decoy Extracellular Vesicles Overcome Triple-Negative Breast Cancer Heterogeneity via Membrane-Cytoplasm-Mitochondria Cascade Targeting.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: June 10, 2025

Construction of a prognostic model and analysis of related mechanisms in breast cancer based on multiple datasets.

Construction of a prognostic model and analysis of related mechanisms in breast cancer based on multiple datasets.

Journal: Translational cancer research

Published: May 23, 2024

Dendritic polylysine co-delivery of paclitaxel and siAXL enhances the sensitivity of triple-negative breast cancer chemotherapy.

Dendritic polylysine co-delivery of paclitaxel and siAXL enhances the sensitivity of triple-negative breast cancer chemotherapy.

Journal: Frontiers in bioengineering and biotechnology

Published: April 10, 2024

Overcoming AZD9291 Resistance and Metastasis of NSCLC via Ferroptosis and Multitarget Interference by Nanocatalytic Sensitizer Plus AHP-DRI-12.

Overcoming AZD9291 Resistance and Metastasis of NSCLC via Ferroptosis and Multitarget Interference by Nanocatalytic Sensitizer Plus AHP-DRI-12.

Journal: Small (Weinheim an der Bergstrasse, Germany)

Published: July 07, 2022

Systemic Delivery of mPEG-Masked Trispecific T-Cell Nanoengagers in Synergy with STING Agonists Overcomes Immunotherapy Resistance in TNBC and Generates a Vaccination Effect.

Systemic Delivery of mPEG-Masked Trispecific T-Cell Nanoengagers in Synergy with STING Agonists Overcomes Immunotherapy Resistance in TNBC and Generates a Vaccination Effect.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: June 19, 2022

Nano-ultrasonic Contrast Agent for Chemoimmunotherapy of Breast Cancer by Immune Metabolism Reprogramming and Tumor Autophagy.

Nano-ultrasonic Contrast Agent for Chemoimmunotherapy of Breast Cancer by Immune Metabolism Reprogramming and Tumor Autophagy.

Journal: ACS nano

Published: February 14, 2022

Engineered PD-1/TIGIT dual-activating cell-membrane nanoparticles with dexamethasone act synergistically to shape the effector T cell/Treg balance and alleviate systemic lupus erythematosus.

Engineered PD-1/TIGIT dual-activating cell-membrane nanoparticles with dexamethasone act synergistically to shape the effector T cell/Treg balance and alleviate systemic lupus erythematosus.

Journal: Biomaterials

Published: January 31, 2022

Precise Targeting Therapy of Orthotopic Gastric Carcinoma by siRNA and Chemotherapeutic Drug Codelivered in pH-Sensitive Nano Platform.

Precise Targeting Therapy of Orthotopic Gastric Carcinoma by siRNA and Chemotherapeutic Drug Codelivered in pH-Sensitive Nano Platform.

Journal: Advanced healthcare materials

Published: May 19, 2021

A paclitaxel and microRNA-124 coloaded stepped cleavable nanosystem against triple negative breast cancer.

A paclitaxel and microRNA-124 coloaded stepped cleavable nanosystem against triple negative breast cancer.

Journal: Journal of nanobiotechnology

Published: September 25, 2020

Asynchronous blockade of PD-L1 and CD155 by polymeric nanoparticles inhibits triple-negative breast cancer progression and metastasis.

Asynchronous blockade of PD-L1 and CD155 by polymeric nanoparticles inhibits triple-negative breast cancer progression and metastasis.

Journal: Biomaterials

Published: September 23, 2020

Showing 1-12 of 18

Last Updated: 09/26/2026